Envoy Medical, Inc. (COCHW) stock
COCHWNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCH
$0.03−0.00 (-15.49%)
Close on Oct 30, 2026Market cap $511.80MP/E –Yield –
Envoy Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Envoy Medical's operating income for the twelve months ending Jun 30, 2026 was -$23.62M. For fiscal 2025 it was -$22.27M. The highest annual figure on record is -$5.20M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.27M | – |
| FY2024 | Dec 31, 2024 | -$19.26M | – |
| FY2023 | Dec 31, 2023 | -$18.36M | – |
| FY2022 | Dec 31, 2022 | -$8.71M | – |
| FY2021 | Dec 31, 2021 | -$5.20M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.57M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.96M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.39M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.07M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.11M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.55M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.97M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.85M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.88M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.72M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.39M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.48M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.77M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.91M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.80M | – |
| Q2 FY2022 | Jun 30, 2022 | -$901.36K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.49M | – |
| Q4 FY2021 | Dec 31, 2021 | -$963.91K | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.99M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.07M | – |
| Q1 FY2021 | Mar 31, 2021 | -$966.28K | – |